Cargando…
Harnessing the Secretome of Mesenchymal Stromal Cells for Traumatic Spinal Cord Injury: Multicell Comparison and Assessment of In Vivo Efficacy
Cell therapy offers significant promise for traumatic spinal cord injury (SCI), which despite many medical advances, has limited treatment strategies. Able to address the multifactorial and dynamic pathophysiology of SCI, cells present various advantages over standard pharmacological approaches. How...
Autores principales: | Vawda, Reaz, Badner, Anna, Hong, James, Mikhail, Mirriam, Dragas, Rachel, Xhima, Kristiana, Jose, Alejandro, Fehlings, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703247/ https://www.ncbi.nlm.nih.gov/pubmed/32962528 http://dx.doi.org/10.1089/scd.2020.0079 |
Ejemplares similares
-
Early Intravenous Infusion of Mesenchymal Stromal Cells Exerts a Tissue Source Age‐Dependent Beneficial Effect on Neurovascular Integrity and Neurobehavioral Recovery After Traumatic Cervical Spinal Cord Injury
por: Vawda, Reaz, et al.
Publicado: (2019) -
Splenic involvement in umbilical cord matrix-derived mesenchymal stromal cell-mediated effects following traumatic spinal cord injury
por: Badner, Anna, et al.
Publicado: (2018) -
Cellular Treatments for Spinal Cord Injury: The Time is Right for Clinical Trials
por: Fehlings, Michael G., et al.
Publicado: (2011) -
Current stem cell treatments for spinal cord injury
por: Vawda, R, et al.
Publicado: (2012) -
Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury
por: Ulndreaj, Antigona, et al.
Publicado: (2017)